Invention Grant
US08637546B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)
失效
作为二肽基肽酶-IV（DDP-IV）抑制剂的药物组合物
- Patent Title: Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DDP-IV)
- Patent Title (中): 作为二肽基肽酶-IV（DDP-IV）抑制剂的药物组合物
-
Application No.: US13437999Application Date: 2012-04-03
-
Publication No.: US08637546B2Publication Date: 2014-01-28
- Inventor: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- Applicant: David J. Madar , Stevan W. Djuric , Melissa J. Michmerhuizen , Hana A. Kopecka , Xiaofeng Li , Kenton L. Longenecker , Zhonghua Pei , Daisy Pireh , Hing L. Sham , Kent D. Stewart , Bruce G. Szczepankiewicz , Paul E. Wiedeman , Hong Yong
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Michael Best & Friedrich, LLP
- Agent Lisa V. Mueller
- Main IPC: A61K31/445
- IPC: A61K31/445 ; C07D295/00
Abstract:
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.
Public/Granted literature
- US20130059873A1 PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) Public/Granted day:2013-03-07
Information query
IPC分类:
